MK-677 (ibutamoren) does not directly suppress the hormonal signals that drive fertility the way anabolic steroids or SARMs do, but it can shift several hormones in directions that matter for reproduction. The effects are indirect and vary between men and women, which makes this a more nuanced question than a simple yes or no.
How MK-677 Differs From SARMs and Steroids
MK-677 is often lumped together with SARMs in online fitness communities, but it works through an entirely different mechanism. SARMs bind directly to androgen receptors and can suppress your body’s natural testosterone production, sometimes severely. Anabolic steroids do the same, often shutting down sperm production in the process. MK-677 doesn’t touch androgen receptors at all. Instead, it mimics a hunger hormone called ghrelin, which tells your pituitary gland to release more growth hormone (GH). That rise in GH then increases levels of IGF-1, a growth factor involved in tissue repair, muscle growth, and metabolism.
Because MK-677 doesn’t act on androgen receptors, it doesn’t cause the same kind of hormonal shutdown that makes steroids and SARMs so damaging to fertility. However, that doesn’t mean it leaves your reproductive hormones untouched.
Effects on Testosterone and Reproductive Hormones in Men
Clinical data from a controlled trial published in Clinical Endocrinology found that MK-677 significantly reduced total testosterone levels compared to placebo. At the same time, the ratio of total testosterone to sex hormone-binding globulin (SHBG), which serves as a proxy for free testosterone, remained unchanged. In practical terms, this means more of your testosterone gets bound up by carrier proteins, but the amount actually available to your tissues stays roughly the same.
Importantly, MK-677 did not alter levels of luteinizing hormone (LH) or follicle-stimulating hormone (FSH). These are the two pituitary hormones that signal your testes to produce testosterone and sperm. Steroids and SARMs suppress both, which is why they can tank sperm counts. MK-677 leaves that signaling pathway intact, which is a meaningful difference for male fertility.
That said, a drop in total testosterone is not something to dismiss. If your baseline testosterone is already on the lower end, even a modest reduction could push you into a range where you notice symptoms like reduced libido or lower energy. And while LH and FSH appear unaffected in clinical settings, most MK-677 users take it for longer durations and sometimes at higher doses than what has been studied, so the real-world picture may not perfectly match trial data.
The Prolactin Problem
One of MK-677’s most consistent hormonal effects is a rise in prolactin. Growth hormone secretagogues tend to bump prolactin levels, and this is where the fertility concern becomes more concrete.
Prolactin at elevated levels (a condition called hyperprolactinemia) is a well-established cause of infertility in both sexes. In women, excess prolactin disrupts the release of GnRH, the master hormone that triggers the cascade leading to ovulation. The result can be irregular or absent periods, failed ovulation, and luteal phase defects where progesterone levels drop too low to support a pregnancy. Prolactin also directly interferes with how ovarian cells respond to FSH, reducing estrogen production and impairing follicle development. Hyperprolactinemia is at least ten times more common in infertile women than in the general population.
In men, elevated prolactin can reduce libido and, in more pronounced cases, contribute to erectile dysfunction and lower sperm quality. The mechanism is similar: too much prolactin suppresses GnRH, which lowers the downstream signals that keep testosterone and sperm production running normally.
The degree of prolactin elevation from MK-677 varies between individuals. Some users report no noticeable issues, while others develop symptoms like tender or swollen breast tissue (gynecomastia in men) or menstrual irregularities in women. If you are actively trying to conceive, even a moderate prolactin increase could work against you.
IGF-1 and Reproductive Function
MK-677 reliably raises IGF-1 levels, often by 40% or more depending on dose and duration. IGF-1 plays a real role in reproductive biology, particularly in women. It helps recruit and mature ovarian follicles, working alongside FSH during the early stages of egg development. Research from IVF outcomes shows that women with very low IGF-1 levels (below roughly 132 ng/mL) had cycle cancellation rates of 25%, compared to just 11.6% in women with higher levels (above 202 ng/mL). Having adequate IGF-1 appears to support the likelihood that at least one viable embryo develops.
But more is not necessarily better. The same data suggests that mid-range IGF-1 levels produce the best overall fertility outcomes. Women with the highest IGF-1 concentrations showed higher miscarriage rates in frozen embryo transfer cycles. The relationship follows a curve: too little IGF-1 impairs follicle growth, but too much may compromise embryo implantation or early pregnancy survival. Pushing IGF-1 well above normal with MK-677 could theoretically tip the balance in the wrong direction, though this has not been studied directly in MK-677 users trying to conceive.
Insulin Resistance as an Indirect Factor
MK-677 consistently worsens insulin sensitivity. Growth hormone opposes insulin’s action, so chronically elevated GH and IGF-1 levels can push your blood sugar higher and make your cells less responsive to insulin over time. This is relevant to fertility because insulin resistance is closely linked to reproductive dysfunction, most notably in polycystic ovary syndrome (PCOS). Women with insulin resistance often have disrupted ovulation, excess androgen production, and difficulty conceiving. Men with significant insulin resistance tend to have lower testosterone and poorer sperm parameters.
If you already have borderline insulin sensitivity, metabolic syndrome, or PCOS, MK-677 could aggravate the metabolic environment that contributes to infertility. This is an indirect pathway, but it compounds the other hormonal shifts.
Contamination and Supplement Risks
MK-677 is not approved for medical use and is sold almost exclusively through unregulated supplement or research chemical markets. Case reports have documented products marketed as MK-677 or stacked with it that contained undisclosed ingredients, including actual testosterone, estradiol, or other hormones. One published case in JCEM Case Reports described a man who developed gynecomastia and biochemical hypogonadism from a commercial performance-enhancing supplement that contained both MK-677 and undisclosed hormonal compounds. His condition reversed after stopping the product.
This matters because the fertility risks you face may not come from MK-677 itself, but from whatever else is in the bottle. Without pharmaceutical-grade quality control, there is no guarantee that the product contains only what the label claims.
Practical Takeaways for People Trying to Conceive
MK-677 is not in the same category as steroids or SARMs when it comes to fertility suppression. It does not shut down LH or FSH, and it does not directly suppress sperm production through androgen receptor activity. But it does lower total testosterone, raise prolactin, push IGF-1 above physiological ranges, and worsen insulin sensitivity. Each of these shifts can nudge your reproductive system in an unfavorable direction, and combined, they represent a meaningful set of risk factors.
For men, the biggest concerns are prolactin-related side effects and the modest testosterone reduction. For women, prolactin elevation poses a more direct threat to ovulation and cycle regularity, while the metabolic effects could worsen conditions like PCOS. If you are planning a pregnancy or struggling with fertility, stopping MK-677 removes these variables from an already complex equation. The hormonal changes it causes appear to be reversible once the compound is discontinued.